PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2024; 07(02): 053-065
DOI: 10.1055/s-0044-1782672
Review Article

Diabetes and Ramadan Fasting (2023): The Year in Review

Hussam Abusahmin
1   Department of Endocrinology, Al Qassimi Hospital, Sharjah, United Arab Emirates
,
Elamin Abdelgadir
2   Department of Endocrinology, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates
,
Mohsen S. Eledrisi 
3   Department of Medicine, Hamad Medical Corporation, Doha, Qatar
4   Department of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar
,
Khadija Hafidh 
5   Department of Endocrinology, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates
6   Department of Medicine, Dubai Medical College for Girls, Dubai, United Arab Emirates
,
Salem A. Beshyah 
6   Department of Medicine, Dubai Medical College for Girls, Dubai, United Arab Emirates
7   Department of Endocrinology, Yas Clinic Khalifa City, Abu Dhabi, United Arab Emirates
› Institutsangaben Funding None.
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Introduction We aimed to provide an overview of the global literature production on diabetes and Ramadan in the past year (2023).

Materials and Methods This is a narrative, nonsystematic review of the international literature from two major medical online databases (PubMed and Google Scholar) in 2023. The search term “Diabetes AND Ramadan fasting” was used, and the relevant literature was narrated in a concise thematic account.

Results The publications spanned a vast array of topics related to diabetes and Ramadan fasting (RF), including physiology and nutrition, risk assessment stratification tools and their validation, assessments of safety and efficacy profiles of older and newer diabetes therapies, diabetes education, use of advanced technology for the treatment, and monitoring and impact on pregnancy. Some reports covered the interaction between Ramadan and COVID-19 concerning diabetes, pregnancy, complications, and unique characteristics of diabetes and fasting by young and older people.

Conclusion The current narration presents this year's global scholarly production on the safety of fasting practices, care models, and patients' experiences and perspectives.

Keywords

physiology - health care professionals - complications - risk stratification - patients' perspectives - Ramadan fasting - COVID-19

Authors' Contributions

All named authors contributed to the article's drafting, revision, and finalization to fulfill the ICMJE authorship criteria.


Compliance with Ethical Principles

Formal ethical approval is not required.




Publikationsverlauf

Artikel online veröffentlicht:
11. April 2024

© 2024. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Beshyah SA. Fasting Ramadan for people with diabetes: medicine and fiqh finally united. Ibnosina J Med Biomed Sci 2009; 1: 1-5
    Google Scholar
  • 2 Beshyah WS, Beshyah SA. Bibliometric analysis of the literature on Ramadan fasting and diabetes in the past three decades (1989-2018). Diabetes Res Clin Pract 2019; 151: 313-322
    CrossrefPubMedGoogle Scholar
  • 3 Beshyah SA, Hajjaji IM, Ibrahim WH. et al. The year in Ramadan fasting research (2017): a narrative review. Ibnosina J Med Biomed Sci 2018; 10: 39-53
    Artikel in Thieme ConnectGoogle Scholar
  • 4 Beshyah SA, Badi A, El-Ghul AM. et al. The year in Ramadan fasting and health (2018). Ibnosina J Med Biomed Sci 2019; 11: 151-170
    Artikel in Thieme ConnectGoogle Scholar
  • 5 Beshyah SA, Ali KF, Hafidh K, Hajjaji IM. Ramadan fasting and diabetes 2019: the year in review. Diabetes Res Clin Pract 2021; 172: 108593
    CrossrefPubMedGoogle Scholar
  • 6 Hafidh K, Ali KF, Abbas S, Beshyah SA. Ramadan fasting and diabetes (2020): the year in review. J Diabetes Endocr Pract 2021; 4: 46-58
    Artikel in Thieme ConnectGoogle Scholar
  • 7 Beshyah SA, Hafidh K, Kenz S. et al. Ramadan fasting and diabetes (2021): the year in review. J Diabetes Endocr Pract 2022; 5 (01) 8-20
    Artikel in Thieme ConnectGoogle Scholar
  • 8 Hafidh K, Besheya TA, Elmehdawi R. et al. Ramadan fasting and diabetes (2022): the year in review. Journal of Diabetes and Endocrine Practice 2023; 6: 104-117
    Artikel in Thieme ConnectGoogle Scholar
  • 9 Jarrar Y, Abdul-Wahab G, Mosleh R. et al. Does Ramadan intermittent fasting affect the fasting blood glucose level among type II diabetic patients?. J Clin Med 2023; 12 (20) 6604
    CrossrefPubMedGoogle Scholar
  • 10 Elmalti A, Mukhtar M, Kenz S, Skaria S, Elgzyri T. Transient increase in glucose variability during Ramadan fasting in patients with insulin-treated type 2 diabetes: a preliminary study. Diabetes Metab Syndr 2023; 17 (04) 102745
    CrossrefPubMedGoogle Scholar
  • 11 Sibarani JP. Effect of Ramadhan fasting on apolipoprotein B and small dense LDL in type 2 diabetes mellitus patients. Int J Health Pharm 2023; 3 (04) 877-883
    Google Scholar
  • 12 Keskinler MV, Dincer B, Caklili OT, Oguz A. The effect of Ramadan fasting on serum osmolality in diabetic patients. J Pak Med Assoc 2023; 73 (04) 767-770
    CrossrefPubMedGoogle Scholar
  • 13 Elmajnoun HK, Faris ME, Abdelrahim DN, Haris PI, Abu-Median AB. Effects of Ramadan fasting on glycaemic control among patients with type 2 diabetes: systematic review and meta-analysis of observational studies. Diabetes Ther 2023; 14 (03) 479-496
    CrossrefPubMedGoogle Scholar
  • 14 Mohammed N, Buckley A, Siddiqui M. et al. Validation of the new IDF-DAR risk assessment tool for Ramadan fasting in patients with diabetes. Diabetes Metab Syndr 2023; 17 (04) 102754
    CrossrefPubMedGoogle Scholar
  • 15 Afandi B, Hassanein M, Shaikh S. et al. Variability among physicians in risk stratification for people with diabetes during Ramadan fasting. Dubai Diabetes Endocrinol J 2023; 28 (04) 1-7
    Google Scholar
  • 16 Noor SK, Alutol MT, FadAllah FSA. et al. Risk factors associated with fasting during Ramadan among individuals with diabetes according to IDF-DAR risk score in Atbara city, Sudan: cross-sectional hospital-based study. Diabetes Metab Syndr 2023; 17 (03) 102743
    CrossrefPubMedGoogle Scholar
  • 17 Kamrul-Hasan ABM, Alam MS, Kabir MA. et al. Risk stratification using the 2021 IDF-DAR risk calculator and fasting experience of Bangladeshi subjects with type 2 diabetes in Ramadan: the DAR-BAN study. J Clin Transl Endocrinol 2023; 31: 100315
    PubMedGoogle Scholar
  • 18 Shaltout I, Abdelwahab AM, El Meligi A. et al. Risk stratification in people with diabetes for fasting during Ramadan: consensus from Arabic Association for the Study of Diabetes and Metabolism. Curr Diabetes Rev 2024; 20 (07) 1-22
    CrossrefPubMedGoogle Scholar
  • 19 Ibrahim M, Barker MM, Ahmad E. et al. Optimizing Ramadan fasting: a randomized controlled trial for people with type 2 diabetes during Ramadan applying the ADA/EASD consensus principles. Diabetes Metab Res Rev 2023; 39 (03) e3604
    CrossrefPubMedGoogle Scholar
  • 20 MacKenzie SC, Mehar S, Barakatun-Nisak MY. et al. Digitizing diabetes education for a safer Ramadan: designing, delivering, and evaluating massive open online courses in Ramadan-focused diabetes education. Br J Diabetes 2023; 23 (02) 137
    Google Scholar
  • 21 Larasati MD, Muninggar DL, Firmansyah F. Development and validation of an educational booklet for the healthy eating management of diabetes mellitus during Ramadan fasting. Jurnal Gizi Prima 2023; 8 (02) 59-67
    Google Scholar
  • 22 Hassanein M, Malek R, Shaltout I. et al; SoliRam Study Investigators. Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: the SoliRam observational study. Diabetes Metab Syndr 2023; 17 (02) 102707
    CrossrefPubMedGoogle Scholar
  • 23 Hassanein M, Shaltout I, Malek R. et al. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes mellitus during the period of Ramadan in four countries (Egypt, Jordan, Lebanon, and Turkey): a prospective observational study. Curr Diabetes Rev 2024; 20 (05) 137-147
    CrossrefPubMedGoogle Scholar
  • 24 Elbarbary NS, Ismail EAR. Mitigating iftar-related glycemic excursions in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed loop system: a randomized clinical trial for adjunctive oral vildagliptin therapy during Ramadan fasting. Diabetol Metab Syndr 2023; 15 (01) 257
    CrossrefPubMedGoogle Scholar
  • 25 Samkari MM, Bokhari NS, Alhajaji R. et al. Safety and tolerability of empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: a prospective cohort study. Saudi Pharm J 2023; 31 (06) 972-978
    CrossrefPubMedGoogle Scholar
  • 26 Sheikh A, Das B, Sattar S, Islam N. Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population: an observational study from a tertiary care center in Karachi. Endocrine 2023; 80 (01) 64-70
    CrossrefPubMedGoogle Scholar
  • 27 Goh KG, Zakaria MH, Raja Azwan RN, Bhajan Singh KK, Badrul Hisham MH, Hussein Z. Effect of empagliflozin in patients with type 2 diabetes during Ramadan on volume status, ketonaemia, and hypoglycaemia. Diabetes Metab Syndr 2023; 17 (01) 102680
    CrossrefPubMedGoogle Scholar
  • 28 Ghazi HA. Safety and tolerability of sodium-glucose co-transporters-2 inhibitors among elderly patients with type 2 diabetes fasting Ramadan. Egypt J Hosp Med 2023; 90 (01) 200-205
    CrossrefGoogle Scholar
  • 29 Lee SWH, Chen WS, Sellappans R, Md Sharif SB, Metzendorf MI, Lai NM. Interventions for people with type 2 diabetes mellitus fasting during Ramadan. Cochrane Database Syst Rev 2023; 7 (07) CD013178
    PubMedGoogle Scholar
  • 30 AlGhatam G, O'Keeffe D, Taha H. Effects of alternate insulin pump settings in patients with type 1 diabetes during Ramadan: a randomized pilot study. J Diabetes Sci Technol 2023; 17 (02) 409-416
    CrossrefPubMedGoogle Scholar
  • 31 Messaoudi N, Bouichrat N, Assarrar I. et al Glycemic control and satisfaction during Ramadan in patients with type 1 diabetes treated with an advanced hybrid closed loop insulin pump. Rev Diabet Stud 19 (01) 08-13
    CrossrefPubMedGoogle Scholar
  • 32 Wannes S, Gamal GM, Fredj MB. et al. Glucose control during Ramadan in a pediatric cohort with type 1 diabetes on MiniMed standard and advanced hybrid closed-loop systems: a pilot study. Diabetes Res Clin Pract 2023; 203: 110867
    CrossrefPubMedGoogle Scholar
  • 33 Al Ozairi E, ElSamad A, Al Kandari J, Hamdan Y, Taliping D, Gray SR. The effect of timing of remotely supervised exercise on glucose control in people with type 1 diabetes during Ramadan: a randomised crossover study. Diabetes Metab Syndr 2023; 17 (09) 102845
    CrossrefPubMedGoogle Scholar
  • 34 Al-Sofiani ME, Petrovski G, Al Shaikh A. et al. The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: lessons from real world users during Ramadan. Diabetes Obes Metab 2024; 26 (03) 937-949
    CrossrefPubMedGoogle Scholar
  • 35 Wannes S, Al Qusayer D, El Abed S, Ben Fredj M. Insulin pump therapy and glucose control during Ramadan fasting in an adolescent with type 1 diabetes: from an open-loop sensor-augmented pump therapy with predictive low-glucose management to an advanced hybrid closed-loop system. Acta Diabetol 2023; 60 (06) 851-855
    CrossrefPubMedGoogle Scholar
  • 36 Litvinova O, Eitenberger M, Bilir A. et al. Patent analysis of digital sensors for continuous glucose monitoring. Front Public Health 2023; 11: 1205903
    CrossrefPubMedGoogle Scholar
  • 37 Alsulami SS, Ghamri KA. Effect of Ramadan fasting on blood glucose level in pregnant women with gestational and type 2 diabetes. Diabetes Metab Syndr Obes 2023; 16: 3105-3113
    CrossrefPubMedGoogle Scholar
  • 38 Alamoudi RM, Theyab A, Shams T. et al. SAT164 hypoglycemia risk and glucose parameters in pregnant women with or without diabetes during fasting Ramadan. J Endocr Soc 2023; 7 (Suppl. 01) bvad114-1028
    Google Scholar
  • 39 Abdullah S, Shumaila, Mughal S, Samuel M, Hossain N. Maternal and perinatal outcome of Ramadan fasting in women with gestational diabetes. Pak J Med Sci 2023; 39 (02) 323-329
    CrossrefPubMedGoogle Scholar
  • 40 Bentaleb M, Sersar I, Bencharif M. et al. Type 1 diabetes mellitus and Ramadan fasting: a case of adolescents and adults from Algeria. Nutr Clin Metab 2023; 37 (04) 214-220
    CrossrefGoogle Scholar
  • 41 Ata F, Khan AA, Khamees I, Bashir M. Incidence of diabetic ketoacidosis does not differ in Ramadan compared to other months and seasons: results from a 6-year multicenter study. Curr Med Res Opin 2023; 39 (08) 1061-1067
    CrossrefPubMedGoogle Scholar
  • 42 Ruqaib AMA, Ghamdi AAA, Jamaan AA. et al. Association between SGLT2 inhibitors and diabetic ketoacidosis among patients fasting in Ramadan. Research Square 2023; (e-pub ahead of print) DOI: 10.21203/rs.3.rs-2466697/v1.
    CrossrefGoogle Scholar
  • 43 Tan CSS, Wong YJ, Tang KF, Lee SWH. Diabetes, Ramadan, and driving - Ensuring patient safety while respecting religious autonomy: a qualitative study. Diabetes Metab Syndr 2023; 17 (02) 102724
    CrossrefPubMedGoogle Scholar
  • 44 Mohammad MS, Mahdy MM, Ibrahim NA, Jalil NA. Effects of Ramadan fasting on diabetic nephropathy in type 2 diabetic patients. QJM: An International Journal of Medicine. 2023; 116 (Suppl. 01) hcad069-474
    Google Scholar
  • 45 Tahapary DL, Rizqa T, Syarira CV. et al. Differential effect of Ramadan fasting on intercellular adhesion molecule-1 (ICAM-1) in diabetes mellitus and non-diabetes mellitus patients. Heliyon 2023; 9 (07) e17273
    CrossrefPubMedGoogle Scholar
  • 46 Akkuş Y, Kiliç SP. Feelings, difficulties and attitudes in relation to fasting: a qualitative study on spiritual coping among Turkish patients with type 2 diabetes. J Relig Health 2023; 62 (06) 4382-4398
    CrossrefPubMedGoogle Scholar
  • 47 Hassanein M, Yousuf S, Ahmedani MY. et al. Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: the DaR global survey. Diabetes Metab Syndr 2023; 17 (07) 102799
    CrossrefPubMedGoogle Scholar
  • 48 Alamoudi RM, Aljohani NJ, Alfadhli EM. et al. Fasting Ramadan in patients with T1DM: Saudi Arabia versus other countries during the COVID-19 pandemic. Diabetes Metab Syndr 2023; 17 (01) 102676
    CrossrefPubMedGoogle Scholar
  • 49 Babiker A, Elbarbary NS, Alaqeel B. et al. Lessons learned from COVID-19 lockdown: an ASPED/MENA study on lifestyle changes and quality of life during Ramadan fasting in children and adolescents living with type 1 diabetes. Clin Med Insights Endocrinol Diabetes 2023 ;16:11795514231203907
    PubMedGoogle Scholar
  • 50 Alabbood M, Alameri R, Alsaffar Y. Evaluation of physicians' approaches for the management of patients with diabetes during Ramadan in Iraq. Diabetes Res Clin Pract 2023; 195: 110188
    CrossrefPubMedGoogle Scholar
  • 51 Hillier KA, Longworth ZL, Vatanparast H. Healthcare professionals knowledge, attitude, practices and perspectives providing care to Muslims in western countries who fast during Ramadan: a scoping review. Appl Physiol Nutr Metab 2024; 49 (04) 415-427
    CrossrefPubMedGoogle Scholar
  • 52 Haque MZ, Ahmed F, Khan SL. et al. Diabetes management and culturally sensitive care: an approach to care for Bangladeshi patients. Clin Med Insights Endocrinol Diabetes 2023 ;16:11795514231210139
    PubMedGoogle Scholar